FLNA · Filana Therapeutics, Inc.
Market Cap
$44.88M
Shares
48.31M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-29 | — | |
| 10-Q | 2026-07-29 | 2026-06-30 | |
| 8-K | 2026-06-15 | 2026-06-11 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-11 | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2025-12-23 | 2025-12-19 | |
| 8-K/A | 2025-12-22 | 2025-10-21 | |
| 8-K | 2025-12-18 | 2025-12-15 | |
| 8-K | 2025-12-17 | 2025-12-12 | |
| 8-K | 2025-12-03 | 2025-11-26 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-24 | 2025-10-23 | |
| 8-K | 2025-10-22 | 2025-10-21 | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-05-27 | 2025-05-23 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-21 | 2025-04-15 | |
| DEF 14A | 2025-04-14 | 2025-05-23 | |
| 8-K | 2025-03-25 | — | |
| 8-K | 2025-03-11 | 2025-03-06 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-07 | — | |
| 8-K | 2024-11-25 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-08 | — | |
| 8-K/A | 2024-10-01 | 2024-09-06 | |
| 8-K | 2024-09-27 | 2024-09-26 | |
| 8-K | 2024-09-17 | 2024-09-13 | |
| 8-K | 2024-09-09 | 2024-09-06 | |
| 8-K/A | 2024-08-09 | 2024-08-08 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-22 | — | |
| 8-K | 2024-07-18 | — | |
| 8-K | 2024-07-17 | 2024-07-15 |
Showing 1–50 of 136 filings
Key facts
CIK
1069530
CUSIP
14817C107
13F (30d)
69 filings
69 filers
Visit website
Investor relations